title: Clinical medicine. Biomarker tests need closer scrutiny, IOM concludes.
authors.forename: Jocelyn
authors.initials: J
authors.lastname: Kaiser
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D035843:Biomedical Research / Q000592:standards*; D002986:Clinical Trials as Topic; D016265:Conflict of Interest; D020869:Gene Expression Profiling; D006801:Humans; D025202:Molecular Diagnostic Techniques; D015969:National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics; D057285:Precision Medicine; D015203:Reproducibility of Results; D014481:United States
chemical_list: D000970:Antineoplastic Agents